Health Risk Factor Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bayer Healthcare LLC
Company donates 2.15 million units of hemophilia drug to World Federation
March 22nd, 2005
Bayer Healthcare LLC, Biological Products Division (Bayer BP), announced it is donating 2.15 million units of Kogenate FS (Antihemophilic Factor [Recombinant], Formulated with Sucrose) to the World Federation of Hemophilia (WFH) The Kogenate FS donation will be distributed by WFH to support the treatment needs of hemophilia patients in 13 countries in southeast and central Asia, the Middle East, Africa, and Central and South America. The specific countries receiving Kogenate FS include Thailand, Mongolia, Nepal, Indonesia, Vietnam, Pakistan, Jordan, Sudan, Eritrea, Cameroon, Nigeria, Venezuela, and the Dominican Republic. It is expected that the...
Source: Health Risk Factor Week (2005-03-22)
|
